These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease. Liu B; Dluzen DE Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209 [TBL] [Abstract][Full Text] [Related]
5. Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter. Hartmann A; Hunot S; Hirsch EC Exp Neurol; 2003 Dec; 184(2):561-4. PubMed ID: 14769349 [No Abstract] [Full Text] [Related]
6. Mechanism of cell death in experimental models of Parkinson's disease. Hirsch EC; Hunot S; Hartmann A Funct Neurol; 2000; 15(4):229-37. PubMed ID: 11213526 [No Abstract] [Full Text] [Related]
7. Research in motion: the enigma of Parkinson's disease pathology spread. Brundin P; Li JY; Holton JL; Lindvall O; Revesz T Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444 [TBL] [Abstract][Full Text] [Related]
8. Researcher's study whether Parkinson's disease impacts body mass index. Naccari C CNS Spectr; 2003 May; 8(5):338. PubMed ID: 12778904 [No Abstract] [Full Text] [Related]
9. [The experimental models of Parkinson's disease in animals]. Grigor'ian GA; Bazian AS Usp Fiziol Nauk; 2007; 38(4):80-8. PubMed ID: 18064910 [TBL] [Abstract][Full Text] [Related]
10. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208 [TBL] [Abstract][Full Text] [Related]
11. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. Halliday GM; Macdonald V; Henderson JM Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651 [TBL] [Abstract][Full Text] [Related]
12. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Mogi M; Kondo T; Mizuno Y; Nagatsu T Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747 [TBL] [Abstract][Full Text] [Related]
13. Idiopathic Parkinson's disease: a review of clinical types and pathology. Olasode BJ Niger J Med; 2001; 10(3):116-20. PubMed ID: 11806009 [TBL] [Abstract][Full Text] [Related]
15. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
16. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease. MacDonald V; Halliday GM Mov Disord; 2002 Nov; 17(6):1166-73. PubMed ID: 12465053 [TBL] [Abstract][Full Text] [Related]
17. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166 [TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease. The apoptosis hypothesis. Stern G Adv Neurol; 1996; 69():101-7. PubMed ID: 8615116 [No Abstract] [Full Text] [Related]